Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Glioma 12Glioblastoma 6Insulinoma 4Congenital Hyperinsulinism 4Brain Neoplasms 4Neuroendocrine Tumors 3Neuroblastoma 3Hypoglycemia 3Hyperinsulinism 3Recurrence 2Parkinson Disease 2Oligodendroglioma 2Gliosarcoma 2Ependymoma 2Astrocytoma 2Thyroid cancer, medullary 1Sarcoma 1Pheochromocytoma 1Parkinsonian Disorders 1Paraganglioma 1Optic Nerve Glioma 1Neoplasms, Neuroepithelial 1Neoplasms 1Lewy Body Disease 1Infant, Newborn, Diseases 1Glucose Metabolism Disorders 1Glioma, Subependymal 1Carcinoma, Medullary 1Carcinoid Tumor 1Beckwith-Wiedemann Syndrome 1

Interventions

Carboplatin 8Filgrastim 6Temozolomide 5Etoposide 5etoposide phosphate 3Vincristine 3Radiotherapy 3Peripheral Blood Stem Cell Transplantation 3Melphalan 2Magnetic Resonance Spectroscopy 2Ifosfamide 2Granulocyte Colony-Stimulating Factor 2Cyproheptadine 2Cyclophosphamide 2Busulfan 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2trioctyl phosphine oxide 1sodium thiosulfate 1sargramostim 1gallium Ga 68 dotatate 1fluorodopa F 18 1antineoplaston AS 2-1 1antineoplaston A10 1Transplantation 1Topotecan 1Thiotepa 1Stem Cell Transplantation 1Radiotherapy, Intensity-Modulated 1Photochemotherapy 1Perfusion Magnetic Resonance Imaging 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Optic Nerve Glioma × fluorodopa F 18 × Clear all
NCT02175745 2017-03-20

18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas

Stanford University

Phase NA Terminated
2 enrolled 7 charts
CNSSarcoma

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Neoplasms, Neuroepithelial, Gliosarcoma, Optic Nerve Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡